{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:20:44Z","timestamp":1787764844827,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>As the most common complication of endoscopic retrograde cholangiopancreatography (ERCP) is acute pancreatitis, researchers have paid due attention to minimize this complication using various drugs, one of which is epinephrine. Therefore, the present study aimed at evaluating the effectiveness of epinephrine spray on the papilla in preventing post-ERCP pancreatitis (PEP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The present double-blind clinical trial was performed on 164 patients undergoing ERCP. Patients in both groups received 50 mg rectal suppository as usual before ERCP. Then, during ERCP, epinephrine or normal saline was sprayed topically on the major papillae. After the intervention, patients were evaluated in terms of the incidence of PEP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The results of the present study revealed that the incidence of PEP in the epinephrine and control groups was 2.4% and 4.9%, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). There was no significant difference between the two groups in terms of the incidence of bleeding after ERCP, number of accidental pancreatic duct cannulation, the increase in vision during common bile duct cannulations, the need for precut sphincterotomy, and the number of hospitalization days (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). In addition, the chance of developing PEP was lower and higher in patients with higher ages (odds ratio [OR]: 0.86;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.030) and biliary sludge (OR: 4.97;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.042), respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>As compared with indomethacin alone (control group), it seems that the administration of epinephrine can be effective in reducing the incidence of PEP, although this relationship was not recognized to be significant in this study and only the age and the presence of sludge had a negative and positive relationship with the incidence of PEP, respectively.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_321_21","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T02:18:03Z","timestamp":1698373083000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Determination of the Effectiveness of Epinephrine Spray on the Papillae in Preventing Pancreatitis after Endoscopic Retrograde Cholangiopancreatography"],"prefix":"10.4103","volume":"12","author":[{"given":"Mohammad","family":"Karami","sequence":"first","affiliation":[{"name":"Departments of Gastroenterology and Hepatology, Shahrekord University of Medical Science, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Salemi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Shahrekord University of Medical Science, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shafigh","family":"Ardestani","sequence":"additional","affiliation":[{"name":"Departments of Gastroenterology and Hepatology, Shahrekord University of Medical Science, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.gie.2015.11.006","article-title":"Endoscopic Retrograde Cholangiopancreatography (ERCP): Core curriculum","volume":"83","author":"Jorgensen","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"34","DOI":"10.14748\/vmf.v6i1.1911","article-title":"Actual role of ERCP in a diagnostic and therapeutically algorithm in a in some biliary tract disease","volume":"6","author":"Georgieva","year":"2017","journal-title":"Varna Med Forum"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"149","DOI":"10.17219\/acem\/66773","article-title":"Post-ERCP pancreatitis: Pathophysiology, early identification and risk stratification","volume":"27","author":"Tryliskyy","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"R4-20240830","first-page":"S1486","article-title":"Risk factors for ERCP-related complications: A prospective multicenter study in Guayaquil, Ecuador: 2742","volume":"112","author":"Alcivar-Leon","year":"2017","journal-title":"Official J Am College of Gastroenterol"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1424-3903(11)80094-3","article-title":"Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: A retrospective analysis of 7,168 cases","volume":"11","author":"Zhou","year":"2011","journal-title":"Pancreatology"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000479494","article-title":"Epinephrine in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A preliminary study","volume":"12","author":"Hatami","year":"2018","journal-title":"Case Rep Gastroenterol"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00535-008-2272-8","article-title":"Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis","volume":"44","author":"Matsushita","year":"2009","journal-title":"J Gastroenterol"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/SMJ.0b013e318290c6be","article-title":"Risk stratification for the development of post-ERCP pancreatitis by sphincter of Oddi dysfunction classification","volume":"106","author":"Beltz","year":"2013","journal-title":"South Med J"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1572-0241.2007.01165.x","article-title":"Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP","volume":"102","author":"Sotoudehmanesh","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1440-1746.2007.05096.x","article-title":"Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis","volume":"23","author":"Khoshbaten","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MPA.0b013e3181f94d46","article-title":"Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A prospective, randomized, double-blind, controlled trial","volume":"40","author":"Yoo","year":"2011","journal-title":"Pancreas"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5009\/gnl.2012.6.2.256","article-title":"The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis","volume":"6","author":"Yoo","year":"2012","journal-title":"Gut Liver"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0016-5107(02)70178-8","article-title":"Nifedipine for prevention of post-ERCP pancreatitis: A prospective, double-blind randomized study","volume":"56","author":"Prat","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0016-5107(03)02540-9","article-title":"The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis","volume":"59","author":"Schwartz","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1440-1746.2011.06718.x","article-title":"Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla","volume":"26","author":"Xu","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11938-018-0194-y","article-title":"Update on the prevention of post-ERCP pancreatitis","volume":"16","author":"Zhang","year":"2018","journal-title":"Curr Treat Options Gastroenterol"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"339","DOI":"10.14309\/ajg.0000000000000049","article-title":"A Randomized trial of topical epinephrine and rectal indomethacin for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients","volume":"114","author":"Kamal","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1046\/j.1440-1746.2001.02483.x","article-title":"Epinephrine irrigation for the prevention of pancreatic damage after endoscopic balloon sphincteroplasty","volume":"16","author":"Ohashi","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5152\/tjg.2015.6000","article-title":"Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials","volume":"26","author":"Shi","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gie.2016.08.034","article-title":"Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: A systematic review and meta-analysis","volume":"85","author":"Inamdar","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"e92922","DOI":"10.1371\/journal.pone.0092922","article-title":"How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis","volume":"9","author":"Puig","year":"2014","journal-title":"PLoS One"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.3748\/wjg.v20.i29.10151","article-title":"Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis?","volume":"20","author":"D\u00f6br\u00f6nte","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R23-20240830","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1556\/OH.2012.29403","article-title":"Effects of rectal indomethacin in the prevention of post-ERCP acute pancreatitis","volume":"153","author":"D\u00f6br\u00f6nte","year":"2012","journal-title":"Orv Hetil"},{"key":"R24-20240830","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/00365528809103966","article-title":"Raised plasma thromboxane B2 levels in experimental acute necrotizing pancreatitis in rats. The effects of flunarizine, dazoxiben, and indomethacin","volume":"23","author":"van Ooijen","year":"1988","journal-title":"Scand J Gastroenterol"},{"key":"R25-20240830","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ajg.2012.442","article-title":"Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data","volume":"108","author":"Elmunzer","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R26-20240830","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-0031-1291440","article-title":"Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: A randomized, double-blind, placebo-controlled trial","volume":"44","author":"Katsinelos","year":"2012","journal-title":"Endoscopy"},{"key":"R27-20240830","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ajg.2014.9","article-title":"A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis","volume":"109","author":"Sotoudehmanesh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R28-20240830","first-page":"522","article-title":"Inflammatory mediators and cytokines \u2013 New aspects of the pathophysiology and assessment of severity of acute pancreatitis?","volume":"40","author":"Gross","year":"1993","journal-title":"Hepatogastroenterology"},{"key":"R29-20240830","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.gie.2014.07.033","article-title":"The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement","volume":"81","author":"Choksi","year":"2015","journal-title":"Gastrointest Endosc"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_321_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:47:50Z","timestamp":1787762870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_321_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_321_21","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2021-10-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}